Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene

Annals of the American Thoracic Society

Volumn 12, Issue 3, 2015, Pages 332-339

  Kim, Victor ^a   Crapo, James ^b   Zhao, Huaqing ^a   Jones, Paul W ^c   Silverman, Edwin K ^d   Comellas, Alejandro ^e   Make, Barry J ^b   Criner, Gerard J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

Chronic bronchitis; Chronic obstructive pulmonary disease; Saint George's respiratory questionnaire

Indexed keywords

ADULT; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COUGHING; DISEASE EXACERBATION; EMPHYSEMA; FEMALE; GOLD STANDARD; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHENOTYPE; SENSITIVITY AND SPECIFICITY; SMOKING; ST. GEORGE RESPIRATORY QUESTIONNAIRE; AGED; BRONCHITIS, CHRONIC; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; MULTICENTER STUDY; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; THORAX RADIOGRAPHY;

ADULT; AGED; BRONCHITIS, CHRONIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RADIOGRAPHY, THORACIC; SEVERITY OF ILLNESS INDEX; SPIROMETRY;

EID: 84961289978     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201411-518OC     Document Type: Article

References (31)

1. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-365.
2. American Lung Association. Trends in COPD (chronic bronchitis and emphysema): morbidity and mortality. 2013 [accessed 2015 Feb. 1]. Available from: http://www.lung.org/finding-cures/our-research/trend-reports/copd-trend-report.pdf
3. Ferris BG. Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis 1978;118:1-120.
4. Vestbo J, Prescott E, Lange P; Copenhagen City Heart Study Group. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Am J Respir Crit Care Med 1996;153:1530-1535.
5. Burgel PR, Nesme-Meyer P, Chanez P, Caillaud D, Carré P, Perez T, Roche N; Initiatives Bronchopneumopathie Chronique Obstructive Scientific Committee. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009;135:975-982.
6. Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax 2009;64:894-900.
7. Kim V, Davey A, Comellas AP, Han MK, Washko G, Martinez CH, Lynch D, Lee JH, Silverman EK, Crapo JD, et al.; COPDGene® Investigators. Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study. Respir Res 2014;15:52.
8. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990;45:579-585.
9. Pallasaho P, Lundbäck B, Läspä SL, Jönsson E, Kotaniemi J, Sovijärvi AR, Laitinen LA. Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki Study. Respir Med 1999;93:798-809.
10. Sobradillo V, Miravitlles M, Jiménez CA, Gabriel R, Viejo JL, Masa JF, Fernández-Fau L, Villasante C. Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation [in Spanish]. Arch Bronconeumol 1999;35:159-166.
11. Janson C, Chinn S, Jarvis D, Burney P. Determinants of cough in young adults participating in the European Community Respiratory Health Survey. Eur Respir J 2001;18:647-654.
12. De Marco R, Accordini S, Cerveri I, Corsico A, Antó JM, Künzli N, Janson C, Sunyer J, Jarvis D, Chinn S, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 2007;175:32-39.
13. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008;359:1543-1554.
14. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-789.
15. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, et al.; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-1138.
16. Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JA Jr, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, et al.; COPD Clinical Research Network. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 2011;365:689-698.
17. Couper D, La Vange LM, Han M, Barr RG, Bleecker E, Hoffman EA, Kanner R, Kleerup E, Martinez FJ, Woodruff PG, et al.; SPIROMICS Research Group. Design of the subpopulations and intermediate outcomes in COPD study (SPIROMICS). Thorax 2014;69:491-494.
18. Han MK, Kim V, Martinez C, Curtis JL, Woodruff PG, Albert RK, Connett J, Criner GJ, Martinez F; COPD Clinical Research Network. Significance of chronic bronchitis in the COPD CRN azithromycin in COPD study [abstract]. Am J Respir Crit Care Med 2012;185:A3736.
19. Kim V, Martinez FJ, Han MK, Criner GJ. Clinical and radiographic characteristics of COPD with and without chronic bronchitis [abstract]. Am J Respir Crit Care Med 2014;189:A5931.
20. Kim V, Sternberg AL, Washko G, Make BJ, Han MK, Martinez F, Criner GJ; National Emphysema Treatment Trial Research Group. Severe chronic bronchitis in advanced emphysema increases mortality and hospitalizations. COPD 2013;10:667-678.
21. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010;7:32-43.
22. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117.
23. Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, Nishimura K, Itoh H, Paré PD, Hogg JC, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000;162:1102-1108.
24. Patel BD, Coxson HO, Pillai SG, Agustí AG, Calverley PM, Donner CF, Make BJ, Müller NL, Rennard SI, Vestbo J, et al.; International COPD Genetics Network. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;178:500-505.
25. Samet JM. A historical and epidemiologic perspective on respiratory symptoms questionnaires. Am J Epidemiol 1978;108:435-446.
26. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-1648.
27. College of General Practitioners. Chronic bronchitis in Great Britain: national survey carried out by the Respiratory Diseases Study Group of the College of General Practitioners. BMJ 1961;2:973-979.
28. McNab GR, Slator EJ, Stewart CJ. Response to a questionnaire on chronic bronchitic symptoms in East Anglia. Br J Prev Soc Med 1966;20:181-188.
29. Foreman MG, De Meo DL, Hersh CP, Reilly JJ, Silverman EK. Clinical determinants of exacerbations in severe, early-onset COPD. Eur Respir J 2007;30:1124-1130.
30. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-1327.
31. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005;2:75-79.